Referring Physicians >> Newsletters >> December 2011 Vascular Newsletter >> Clinical Research: Active Trials in Vascular Surgery
Clinical trials are evaluating new diagnostic tests and treatments for thoracic and abdominal aortic aneurysm, aortic dissection, carotid stenosis, claudication, critical limb ischemia, deep venous thrombosis, renal artery stenosis, and thoracic aortic injury.
Active vascular surgery trials in the UW Department of Surgery that are currently recruiting participants:
The purpose of this Phase 2 study is to optimize Plasmin delivery by comparing four different delivery regimens in patients with acute peripheral arterial occlusion.The study will also compare Plasmin to placebo and to plasminogen activators.
This study is being conducted to demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield® Embolic Protection System and Emboshield® Pro Embolic Protection System with the Xact® Carotid Stent System to carotid endarterectomy (CEA) for the treatment of asymptomatic extracranial carotid atherosclerotic disease.
The primary goal of this study is to 1) Provide additional information that the commercially available Abbott Vascular Carotid Stent Systems and Embolic Protection Systems can be used successfully by a wide range of physicians under commercial use conditions. 2) Provide an ongoing post-market surveillance mechanism for documentation of clinical outcomes and for possible extension of the Centers for Medicare and Medicaid Services (CMS) coverage to a broader group of patients.
The purpose of the study is to evaluate the safety and effectiveness of the Lombard Medical endovascular Aorfix™ AAA bifurcated stent graft in the treatment of abdominal aortic, aorto-iliac and common iliac aneurysms. In aneurysms with anatomy including angled aorta, angled aneurysmal body or both between 0° and 90°, where the patients have suitable anatomy.
The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.
For access to more trials, or to learn more about our ongoing cutting-edge basic science, clinical and translational research in the Division of Vascular Surgery, please click here.